Zevra Therapeutics, Inc. (ZVRA)
10.67
-0.34
(-3.09%)
USD |
NASDAQ |
May 18, 12:04
Zevra Therapeutics Research and Development Expense (Quarterly) : 4.34M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 66.21M |
| Journey Medical Corp. | 0.00 |
| Corcept Therapeutics, Inc. | 66.26M |
| Assertio Holdings, Inc. | 0.454M |
| Johnson & Johnson | 3.495B |